TAS-102 in metastatic colorectal cancer (mCRC): efficacy, tolerability, and quality of life in heavily pretreated elderly patients: a real-life study

• Main Authors: Giuseppe Cicero (Author), Raffaele Addeo (Author), Rossella De Luca (Author), Giuseppe Lo Re (Author), Leonardo Gulotta (Author), Pierenrico Marchesa (Author), Gaspare Gulotta (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2020-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: TAS-102 is an oral monotherapy, combining trifluridine and tipiracil hydrochloride, indicated for the treatment of pretreated metastatic colorectal cancer (mCRC). The aim of this real-life study is to evaluate the efficacy and safety of TAS-102 in heavily pretreated elderly patients with...